Advances and challenges in chimeric antigen receptor-natural killer cell immunotherapy for cancer

被引：0
|
作者：
Rafei, Hind [1 ]
Rezvani, Katayoun [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2025年 / 206卷 / 02期
基金：
美国国家卫生研究院;
关键词：
CAR-NK; immunotherapy; NK cells;
D O I：
10.1111/bjh.19939
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Chimeric antigen receptor (CAR)-natural killer (NK)-cell therapy has emerged as a promising strategy in the treatment of haematological malignancies and solid cancers. Leveraging the innate immune properties of NK cells, CAR-NK-cell therapies offer potential advantages for cell therapy, including safety of use in the allogeneic setting and reduced risk of toxicity. This Nutshell provides an overview of the latest advancements in CAR-NK-cell therapy and the challenges that remain.
引用
收藏
页码：443 / 446
页数：4
相关论文
共 50 条
  • [41] Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
    Gong, Ying
    Klein Wolterink, Roel G. J.
    Wang, Jianxiang
    Bos, Gerard M. J.
    Germeraad, Wilfred T. V.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [42] PRDM1 knockout chimeric antigen receptor-natural killer cells exhibit durable anti-tumor efficacy
    Nakashima, Takahiro
    Yoshikawa, Toshiaki
    Matsukawa, Tetsuya
    Ito, Yusuke
    Inoue, Satoshi
    Iida, Shinsuke
    Kagoya, Yuki
    CANCER SCIENCE, 2025, 116 : 98 - 98
  • [43] The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
    Yao, Pin
    Liu, Ya-Guang
    Huang, Gang
    Hao, Liangchun
    Wang, Runan
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [44] Natural Killer Cell-Based Immunotherapy for Cancer: Advances and Prospects
    Hu, Yuan
    Tian, Zhigang
    Zhang, Cai
    ENGINEERING, 2019, 5 (01) : 106 - 114
  • [45] Chimeric antigen-specific T-Lymphocytes and natural Killer Cells for Cancer Immunotherapy
    Tonn, T.
    Suck, G.
    Obenaus, M.
    Uharek, L.
    TRANSFUSIONSMEDIZIN, 2016, 6 (03) : 130 - 139
  • [46] Advances in Chimeric Antigen Receptor Immunotherapy for Chronic Lymphocytic Leukemia
    Riches, John C.
    Gribben, John G.
    DISCOVERY MEDICINE, 2013, 16 (90) : 295 - 302
  • [47] Advances Of Chimeric Antigen Receptor T Cell Therapy In Ovarian Cancer
    Yan, Wenying
    Hu, Hongmei
    Tang, Biao
    ONCOTARGETS AND THERAPY, 2019, 12 : 8015 - 8022
  • [48] Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer
    Philippa R. Kennedy
    Martin Felices
    Jeffrey S. Miller
    Stem Cell Research & Therapy, 13
  • [49] Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer
    Kennedy, Philippa R.
    Felices, Martin
    Miller, Jeffrey S.
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [50] The transfection of natural killer T cells with a tumor-antigen specific chimeric antigen receptor (CAR) for melanoma immunotherapy
    Simon, B.
    Wiesinger, M.
    Maerz, J.
    Wistuba-Hamprecht, K.
    Weide, B.
    Schuler-Thurner, B.
    Schuler, G.
    Doerrie, J.
    Uslu, U.
    EXPERIMENTAL DERMATOLOGY, 2019, 28 (03) : E56 - E57
12345